[68Ga]Ga-CXCR4 PET/CT显像评估高级别胶质瘤CXCR4受体表达
前瞻性单中心研究纳入26例未经治疗、活检证实的高级别胶质瘤患者,行[68Ga]Ga-CXCR4 PET/CT显像。患者水平敏感度96.2%,病灶水平敏感度96.4%;CNS WHO 4级病灶SUVmax中位数3.03(IQR 2.5-3.7)高于3级病灶1.51(IQR 1.2-1.8),p=0.0145。作者认为该新型示踪剂应用具有优良的视觉和半定量诊断特性,需进一步研究。
要点
- 患者水平敏感度96.2%,病灶水平敏感度96.4%(28个病理病灶)。
- 4级病灶SUVmax中位数3.03(IQR 2.5-3.7)高于3级病灶1.51(IQR 1.2-1.8),p=0.0145。
- 除膀胱外,示踪剂活性最高位于Waldeyer环淋巴组织(平均SUVmax 7.41)和脾脏(平均SUVmax 6.62)。
核心结论
- 作者认为[68Ga]Ga-Pentixafor PET示踪剂这一新应用表现出优良的视觉和半定量诊断特性,需进一步研究。
研究设计与样本
- 前瞻性单中心研究,纳入26例未经治疗、活检证实的高级别胶质瘤患者(平均年龄53.3±14.4岁,女11例、男15例),行[68Ga]Ga-CXCR4 PET/CT显像并定性及半定量分析。
关键影像表现/征象
- CNS WHO 3级病理占19%(5/26)。
- 共检出28个病理病灶,病灶水平敏感度96.4%。
- 除膀胱作为主要排泄库外,示踪剂活性最高位于Waldeyer环淋巴组织(平均SUVmax 7.41)和脾脏(平均SUVmax 6.62)。
诊断标准与关键数值
- 患者水平68Ga-CXCR4敏感度96.2%。
- 病灶水平敏感度96.4%,基于28个病理病灶。
- 4级病灶SUVmax中位数3.03(IQR 2.5-3.7)vs 3级病灶1.51(IQR 1.2-1.8),p=0.0145。
临床应用与阅片要点
- 作者认为该新型示踪剂应用具有优良的视觉和半定量诊断特性,需进一步研究。
局限性
- 原文结论指出需进一步研究(Further studies are warranted)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.
MATERIALS AND METHODS: [68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.
RESULT: A total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).
CONCLUSION: In conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.
引用
- Roustaei H, Vosoughi H, Askari E, et al. [68 Ga]Ga-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression. Eur J Radiol. 2024. PMID: 39213763. doi:10.1016/j.ejrad.2024.111694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。